Litcius/Paper detail

Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma

Leonardo Gomes da Fonseca, María Reig, Jordi Bruix

2020Clinics in Liver Disease70 citationsDOI

Topics & Concepts

SorafenibMedicineHepatocellular carcinomaMalignancyMonoclonal antibodyTyrosine kinaseTyrosine-kinase inhibitorOncologyInternal medicineCancer researchAntibodyCancerImmunologyReceptorHepatocellular Carcinoma Treatment and PrognosisCancer Mechanisms and TherapyLiver physiology and pathology
Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma | Litcius